Krebs Biochemicals & Industries Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 167.655 million compared to INR 65.18 million a year ago. Net loss was INR 63.903 million compared to INR 78.47 million a year ago. Basic loss per share from continuing operations was INR 3.26 compared to INR 4.93 a year ago. For the half year, total revenue was INR 283.847 million compared to INR 113.566 million a year ago. Net loss was INR 131.118 million compared to INR 154.337 million a year ago. Basic loss per share from continuing operations was INR 6.68 compared to INR 9.7 a year ago. Diluted loss per share from continuing operations was INR 5.81 compared to INR 9.7 a year ago.